BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  FDA

  FDA’s Approval of T2 Biosystems T2Bacteria Panel Underlines Importance of Sepsis Diagnosis and Treatment

  On May 29, the FDA cleared T2 Biosystems’ T2Bacteria Panel for diagnosis of sepsis. In that sepsis is the third-leading cause of death in the U.S., this emphasizes the importance of work in this area.

  July 10, 2018

   · 

  4 min read

   · 

  Mark Terry
• 

  Policy

  Trump Decries Pfizer Over Second Round of Price Increases for Prescriptions

  President Donald Trump used the power of his Twitter feed to call out and condemn pharma giant Pfizer after that company increased the price of a number of its prescription medications by nearly 10 percent.

  July 10, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Roivant Taps Genentech Veteran as Operating Chair Ahead of Pipeline Day

  Changes continue coming to Vivek Ramaswamy’s Roivant Sciences following a June shakeup that saw a 10 percent cut in employment and the restructuring of its business operations.

  July 10, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  The Fleeting Benefits of Vacation: How to Make the Positivity Last When You Return to Work

  How do you feel about taking a vacation? Are you excited and enthusiastic about having time away from work? Or do you have nightmares about the amount of work that would pile up in your absence?

  July 10, 2018

   · 

  4 min read

   · 

  Porschia Parker
• 

  Drug Development

  Beleaguered Regulus Therapeutics Slashes 60 Percent of Workforce in New Corporate Restructuring

  Shares of Regulus Therapeutics saw something of a slight rally on Monday following a post-Independence Day corporate restructuring announcement that included the termination of 60 percent of its workforce, which caused a massive stock plummet.

  July 10, 2018

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  BioNTech and Genevant Forge mRNA Therapeutics Development Agreement

  BioNTech AG and Genevant Sciences entered into a strategic partnership to develop five therapeutics to treat rare diseases.

  July 10, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  Former Rockwell Medical CEO Files Lawsuit, Company Files Counter Lawsuit in Ongoing Legal Battle

  Legal battles are continuing between the Rockwell Medical Board of Directors and two senior executives who were fired earlier this year.

  July 10, 2018

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Celgene and Acceleron’s Luspatercept Hits Primary Endpoints in Beta-Thalassemia Trial

  Celgene Corporation and Acceleron Pharma indicated their Phase III clinical trial of luspatercept in beta-thalassemia hit its primary endpoint of erythroid response.

  July 10, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  UK’s Wellcome Trust to Invest $330 Million into High-Risk Life Science Research

  The UK’s Wellcome Trust, a charitable foundation, announced it is creating the $330 million Leap Fund to invest in high-risk healthcare and life science research.

  July 10, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Allogene Therapeutics Announces the Formation of its Scientific Advisory Board

  Allogene Therapeutics announced the implementation of its Scientific Advisory Board (SAB). The SAB is made up of five leaders in oncology, immunology, drug discovery and development, and will consult on strategic and scientific matters.

  July 10, 2018

   · 

  3 min read

   · 

  Mark Terry